Is Rituximab Ready for Prime Time in SSc? (CME/CE)

(MedPage Today) -- Experts: new data support rituximab for reducing lung fibrosis in systemic sclerosis.
Source: MedPage Today Pulmonary - Category: Respiratory Medicine Source Type: news